Cutting Edge Haematology: Response and Resistance to Targeted Therapies
Professor Mark Dawson Head of the Translational Haematology Program, Group leader of the Cancer Epigenetics Laboratory and Consultant Haematologist in the Department of Haematology, Peter MacCallum Cancer Centre
The interplay between insulin and the NPY system
Dr Kim Loh St Vincent's Institute
“Signalling without catalysis: a pseudokinase perspective”
Dr Isabelle Lucet Walter and Eliza Hall Institute
10% of the time it works every time!
Dr C. Glenn Begley Biocurate
Multiplexing texture and luminance to detect figure-ground boundaries
DR CURTIS BAKER Deptof Ophthalmology, McGill University, Canada
“Eribulin (Halaven®) Mechanisms of Action: Beyond Antimitotic Effects to Complex Changes in Tumor Biology”
Dr Bruce Littlefield Eisai Inc.
Heidelberg, VIC , 3084
Hudson Seminar Series – Dr Justin Dean presenting ‘Mechanisms of Cellular Dysmaturation in Preterm Brain Injury’
Dr Justin Dean - Senior Lecturer in the Department of Physiology, the University of Auckland
Public Lecture: Changing the way we manage diabetes and its complications
Professor Mark Cooper AO Head, Department of Diabetes, Monash University
Department of Medicine-Western Health Research EXPO
Prof. Koen Milisen Leuven University
St. Albans, 3021
Getting on the nerves of cancer: targetting neural regulation to stop metastasis.
Dr Erica Sloan Cancer & Neural-Immune Research Laboratory, Monash Institute of Pharmaceutical Sciences